Rafael Carretero Selected Research

Rafael Carretero Research Topics

12	Neoplasms (Cancer) 01/2022 - 08/2008
6	Neoplasm Metastasis (Metastasis) 03/2015 - 08/2008
4	Melanoma (Melanoma, Malignant) 01/2022 - 08/2008
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2013 - 01/2009
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Adenocarcinoma 03/2015
1	Breast Neoplasms (Breast Cancer) 08/2013
1	Urinary Bladder Neoplasms (Bladder Cancer) 08/2011
1	Inflammation (Inflammations) 03/2010
1	Kidney Neoplasms (Kidney Cancer) 03/2010
1	Lymphadenopathy 01/2009
1	Disease Progression 01/2009
1	Prostatic Neoplasms (Prostate Cancer) 12/2008

4	CytokinesIBA 01/2022 - 11/2008
2	AntibodiesIBA 01/2022 - 03/2015
2	ChemokinesIBA 05/2009 - 12/2008
2	Histocompatibility Antigens Class IIBA 11/2008 - 08/2008
1	Cell Surface ReceptorsIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	GTP-Binding Proteins (G-Protein)IBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	Carcinoembryonic AntigenIBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	Cell Adhesion MoleculesIBA 01/2022
1	Mucin-3IBA 01/2022
1	CEACAM1 ProteinIBA 01/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2016
1	Chemotactic FactorsIBA 06/2015
1	Epidermal Growth Factor (EGF)IBA 03/2015
1	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 03/2015
1	ProteomeIBA 08/2013
1	Oxidoreductases (Dehydrogenase)IBA 08/2013
1	Proteins (Proteins, Gene)FDA Link 08/2013
1	Sulfhydryl Compounds (Thiols)IBA 08/2013
1	boron oxide (BO2)IBA 08/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013
1	InterferonsIBA 07/2012
1	HLA-DR Antigens (HLA-DR)IBA 07/2012
1	HLA-A Antigens (HLA-A)IBA 07/2012
1	HLA Antigens (Human Leukocyte Antigens)IBA 08/2011
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 08/2011
1	Interleukin-18 (Interleukin 18)IBA 03/2010
1	InterleukinsIBA 01/2009
1	Interleukin-10 (Interleukin 10)IBA 01/2009
1	Chemokine CCL5IBA 12/2008
1	Immunologic Factors (Immunomodulators)IBA 11/2008
1	Cancer VaccinesIBA 11/2008